Skip to main
CRM

Salesforce (CRM) Stock Forecast & Price Target

Salesforce (CRM) Analyst Ratings

Based on 38 analyst ratings
Buy
Strong Buy 34%
Buy 34%
Hold 26%
Sell 5%
Strong Sell 0%

Bulls say

Salesforce is benefiting from a compelling mix of durable CRM leadership, expanding AI monetization, and strong customer retention across its core platform, with management highlighting record pipeline, accelerating cRPO growth to 14% in Q2, and rising contract lengths. Its agentic stack—Data 360, Agentforce, and AIforce—positions it to capture a large AI spending opportunity while Agentforce and Data ARR reached $3.9 billion, up 210% year over year, and Slack seats are emerging as a particularly strong growth driver. Even with Commerce, Marketing, Tableau, and MuleSoft still acting as drags, positive enterprise spend commentary, expanding seat adoption, and improving profitability support a reacceleration thesis and a favorable fundamental outlook.

Bears say

Salesforce is exposed to meaningful downside from macro deterioration, as its large global footprint makes it vulnerable to weaker enterprise IT spending and slower deal cycles. Competitive and strategic risk is also elevated, because agentic AI could let rivals differentiate in marketing automation and customer service, pressuring Salesforce’s leadership in key product areas. Financially, the case for caution is reinforced by margin uncertainty and capital allocation risk, since management’s appetite for large deals resurfaced with the $8b Informatica acquisition after the $28b Slack deal in 2021.

Salesforce (CRM) has been analyzed by 38 analysts, with a consensus rating of Buy. 34% of analysts recommend a Strong Buy, 34% recommend Buy, 26% suggest Holding, 5% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Salesforce and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Salesforce (CRM) Forecast

Analysts have given Salesforce (CRM) a Buy based on their latest research and market trends.

According to 38 analysts, Salesforce (CRM) has a Buy consensus rating as of Oct 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $278.47, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $278.47, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Salesforce (CRM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.